Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective...
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative
About this item
Full title
Author / Creator
Vince, Randy A. , Jiang, Ralph , Qi, Ji , Tosoian, Jeffrey J. , Takele, Rebecca , Feng, Felix Y. , Linsell, Susan , Johnson, Anna , Shetty, Sughand , Hurley, Patrick , Miller, David C. , George, Arvin , Ghani, Khurshid , Sun, Fionna , Seymore, Mariana , Dess, Robert T. , Jackson, William C. , Schipper, Matthew , Spratt, Daniel E. and Morgan, Todd M.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background
Decipher Biopsy is a commercially available gene expression classifier used in risk stratification of newly diagnosed prostate cancer (PCa). Currently, there are no prospective data evaluating its clinical utility. We seek to assess the clinical utility of Decipher Biopsy in localized PCa patients.
Methods
A multi-institutional...
Alternative Titles
Full title
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative
Authors, Artists and Contributors
Author / Creator
Jiang, Ralph
Qi, Ji
Tosoian, Jeffrey J.
Takele, Rebecca
Feng, Felix Y.
Linsell, Susan
Johnson, Anna
Shetty, Sughand
Hurley, Patrick
Miller, David C.
George, Arvin
Ghani, Khurshid
Sun, Fionna
Seymore, Mariana
Dess, Robert T.
Jackson, William C.
Schipper, Matthew
Spratt, Daniel E.
Morgan, Todd M.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8770695
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8770695
Other Identifiers
ISSN
1365-7852
E-ISSN
1476-5608
DOI
10.1038/s41391-021-00428-y
